Express Pharma
Home  »  Latest Updates  »  Strides Shasun posts Q4 FY18 and FY18 results

Strides Shasun posts Q4 FY18 and FY18 results

22

Revenues were at ₹ 6,775 million in Q4 FY18

Strides Shasun has announced its Q4 FY18 and FY18 results. In Q4 FY18, revenues were at ₹ 6,775 million, EBITDA at ₹ 1,005 million. In FY18, revenues were at ₹ 28,576 million and EBITDA at ₹ 4,369 million. The board recommended a dividend of ₹ 2 per share.

Arun Kumar, Group CEO and Managing Director, Strides Shasun, said, “The financial year 2017-18 was a difficult year for Strides. While we continue to build momentum with our strategy, our execution was far from satisfactory. We completed several of our corporate actions including exiting non-core operations and markets that did not add value to our overall goal of being a diversified B2C player globally.”

“In 2018-19 our clear focus will be on the improving the quality of growth which will deliver a strong bounce back in the second half of FY 19.”

Comments are closed.